<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-08-15" modified="2020-10-07" version="159">
<accession>Q9NYF0</accession>
<accession>A8MYJ2</accession>
<accession>Q86TY0</accession>
<name>DACT1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Dapper homolog 1</fullName>
<shortName>hDPR1</shortName>
</recommendedName>
<alternativeName>
<fullName>Dapper antagonist of catenin 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Hepatocellular carcinoma novel gene 3 protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">DACT1</name>
<name type="synonym">DPR1</name>
<name type="synonym">HNG3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="Nature" volume="421" first="601" last="607">
<title>The DNA sequence and analysis of human chromosome 14.</title>
<authorList>
<person name="Heilig R."/>
<person name="Eckenberg R."/>
<person name="Petit J.-L."/>
<person name="Fonknechten N."/>
<person name="Da Silva C."/>
<person name="Cattolico L."/>
<person name="Levy M."/>
<person name="Barbe V."/>
<person name="De Berardinis V."/>
<person name="Ureta-Vidal A."/>
<person name="Pelletier E."/>
<person name="Vico V."/>
<person name="Anthouard V."/>
<person name="Rowen L."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Sun H."/>
<person name="Du H."/>
<person name="Pepin K."/>
<person name="Artiguenave F."/>
<person name="Robert C."/>
<person name="Cruaud C."/>
<person name="Bruels T."/>
<person name="Jaillon O."/>
<person name="Friedlander L."/>
<person name="Samson G."/>
<person name="Brottier P."/>
<person name="Cure S."/>
<person name="Segurens B."/>
<person name="Aniere F."/>
<person name="Samain S."/>
<person name="Crespeau H."/>
<person name="Abbasi N."/>
<person name="Aiach N."/>
<person name="Boscus D."/>
<person name="Dickhoff R."/>
<person name="Dors M."/>
<person name="Dubois I."/>
<person name="Friedman C."/>
<person name="Gouyvenoux M."/>
<person name="James R."/>
<person name="Madan A."/>
<person name="Mairey-Estrada B."/>
<person name="Mangenot S."/>
<person name="Martins N."/>
<person name="Menard M."/>
<person name="Oztas S."/>
<person name="Ratcliffe A."/>
<person name="Shaffer T."/>
<person name="Trask B."/>
<person name="Vacherie B."/>
<person name="Bellemere C."/>
<person name="Belser C."/>
<person name="Besnard-Gonnet M."/>
<person name="Bartol-Mavel D."/>
<person name="Boutard M."/>
<person name="Briez-Silla S."/>
<person name="Combette S."/>
<person name="Dufosse-Laurent V."/>
<person name="Ferron C."/>
<person name="Lechaplais C."/>
<person name="Louesse C."/>
<person name="Muselet D."/>
<person name="Magdelenat G."/>
<person name="Pateau E."/>
<person name="Petit E."/>
<person name="Sirvain-Trukniewicz P."/>
<person name="Trybou A."/>
<person name="Vega-Czarny N."/>
<person name="Bataille E."/>
<person name="Bluet E."/>
<person name="Bordelais I."/>
<person name="Dubois M."/>
<person name="Dumont C."/>
<person name="Guerin T."/>
<person name="Haffray S."/>
<person name="Hammadi R."/>
<person name="Muanga J."/>
<person name="Pellouin V."/>
<person name="Robert D."/>
<person name="Wunderle E."/>
<person name="Gauguet G."/>
<person name="Roy A."/>
<person name="Sainte-Marthe L."/>
<person name="Verdier J."/>
<person name="Verdier-Discala C."/>
<person name="Hillier L.W."/>
<person name="Fulton L."/>
<person name="McPherson J."/>
<person name="Matsuda F."/>
<person name="Wilson R."/>
<person name="Scarpelli C."/>
<person name="Gyapay G."/>
<person name="Wincker P."/>
<person name="Saurin W."/>
<person name="Quetier F."/>
<person name="Waterston R."/>
<person name="Hood L."/>
<person name="Weissenbach J."/>
</authorList>
<dbReference type="PubMed" id="12508121"/>
<dbReference type="DOI" id="10.1038/nature01348"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<title>Full-length cDNA libraries and normalization.</title>
<authorList>
<person name="Li W.B."/>
<person name="Gruber C."/>
<person name="Jessee J."/>
<person name="Polayes D."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 212-836 (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao" volume="17" first="280" last="287">
<title>Cloning of a murine cDNA and its human homolog encoding transcription factor-like proteins.</title>
<authorList>
<person name="Gong S."/>
<person name="Qian X."/>
<person name="Fu W."/>
<person name="Chen W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 248-836 (ISOFORM 1)</scope>
<scope>VARIANT VAL-464</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2002" name="Dev. Cell" volume="2" first="449" last="461">
<title>Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation.</title>
<authorList>
<person name="Cheyette B.N.R."/>
<person name="Waxman J.S."/>
<person name="Miller J.R."/>
<person name="Takemaru K."/>
<person name="Sheldahl L.C."/>
<person name="Khlebtsova N."/>
<person name="Fox E.P."/>
<person name="Earnest T.N."/>
<person name="Moon R.T."/>
</authorList>
<dbReference type="PubMed" id="11970895"/>
<dbReference type="DOI" id="10.1016/s1534-5807(02)00140-5"/>
</citation>
<scope>IDENTIFICATION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="1607" last="1614">
<title>HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.</title>
<authorList>
<person name="Yau T.O."/>
<person name="Chan C.Y."/>
<person name="Chan K.L."/>
<person name="Lee M.F."/>
<person name="Wong C.M."/>
<person name="Fan S.T."/>
<person name="Ng I.O."/>
</authorList>
<dbReference type="PubMed" id="15580286"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208340"/>
</citation>
<scope>FUNCTION</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="8607" last="8612">
<title>Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation.</title>
<authorList>
<person name="Zhang L."/>
<person name="Gao X."/>
<person name="Wen J."/>
<person name="Ning Y."/>
<person name="Chen Y.G."/>
</authorList>
<dbReference type="PubMed" id="16446366"/>
<dbReference type="DOI" id="10.1074/jbc.m600274200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DVL2</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="FASEB J." volume="21" first="682" last="690">
<title>The evolutionally conserved activity of Dapper2 in antagonizing TGF-beta signaling.</title>
<authorList>
<person name="Su Y."/>
<person name="Zhang L."/>
<person name="Gao X."/>
<person name="Meng F."/>
<person name="Wen J."/>
<person name="Zhou H."/>
<person name="Meng A."/>
<person name="Chen Y.-G."/>
</authorList>
<dbReference type="PubMed" id="17197390"/>
<dbReference type="DOI" id="10.1096/fj.06-6246com"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="35679" last="35688">
<title>Dapper1 is a nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus.</title>
<authorList>
<person name="Gao X."/>
<person name="Wen J."/>
<person name="Zhang L."/>
<person name="Li X."/>
<person name="Ning Y."/>
<person name="Meng A."/>
<person name="Chen Y.G."/>
</authorList>
<dbReference type="PubMed" id="18936100"/>
<dbReference type="DOI" id="10.1074/jbc.m804088200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CTNNB1 AND HDAC1</scope>
<scope>MUTAGENESIS OF LEU-132; ILE-136 AND 622-LYS-LYS-623</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="BMC Biochem." volume="12" first="33" last="33">
<title>All Dact (Dapper/Frodo) scaffold proteins dimerize and exhibit conserved interactions with Vangl, Dvl, and serine/threonine kinases.</title>
<authorList>
<person name="Kivimae S."/>
<person name="Yang X.Y."/>
<person name="Cheyette B.N."/>
</authorList>
<dbReference type="PubMed" id="21718540"/>
<dbReference type="DOI" id="10.1186/1471-2091-12-33"/>
</citation>
<scope>INTERACTION WITH HDAC1 AND GSK3A</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="14870" last="14880">
<title>Protein kinase A-mediated 14-3-3 association impedes human Dapper1 to promote dishevelled degradation.</title>
<authorList>
<person name="Chen H."/>
<person name="Liu L."/>
<person name="Ma B."/>
<person name="Ma T.M."/>
<person name="Hou J.J."/>
<person name="Xie G.M."/>
<person name="Wu W."/>
<person name="Yang F.Q."/>
<person name="Chen Y.G."/>
</authorList>
<dbReference type="PubMed" id="21262972"/>
<dbReference type="DOI" id="10.1074/jbc.m110.211607"/>
</citation>
<scope>PHOSPHORYLATION AT SER-237 AND SER-827</scope>
<scope>INTERACTION WITH YWHAB</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E34004" last="E34004">
<title>Oncogenic function of DACT1 in colon cancer through the regulation of beta-catenin.</title>
<authorList>
<person name="Yuan G."/>
<person name="Wang C."/>
<person name="Ma C."/>
<person name="Chen N."/>
<person name="Tian Q."/>
<person name="Zhang T."/>
<person name="Fu W."/>
</authorList>
<dbReference type="PubMed" id="22470507"/>
<dbReference type="DOI" id="10.1371/journal.pone.0034004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GSK3B AND CTNNB1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="1450" last="1455">
<title>Identification of novel rare mutations of DACT1 in human neural tube defects.</title>
<authorList>
<person name="Shi Y."/>
<person name="Ding Y."/>
<person name="Lei Y.P."/>
<person name="Yang X.Y."/>
<person name="Xie G.M."/>
<person name="Wen J."/>
<person name="Cai C.Q."/>
<person name="Li H."/>
<person name="Chen Y."/>
<person name="Zhang T."/>
<person name="Wu B.L."/>
<person name="Jin L."/>
<person name="Chen Y.G."/>
<person name="Wang H.Y."/>
</authorList>
<dbReference type="PubMed" id="22610794"/>
<dbReference type="DOI" id="10.1002/humu.22121"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH DVL2</scope>
<scope>POSSIBLE INVOLVEMENT IN NTD</scope>
<scope>VARIANTS NTD TRP-45 AND LYS-356</scope>
<scope>VARIANTS GLY-142; GLY-702; GLY-800 AND LYS-808</scope>
<scope>CHARACTERIZATION OF VARIANTS NTD TRP-45 AND LYS-356</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="373" last="377">
<title>Heterozygous pathogenic variant in DACT1 causes an autosomal-dominant syndrome with features overlapping Townes-Brocks syndrome.</title>
<authorList>
<person name="Webb B.D."/>
<person name="Metikala S."/>
<person name="Wheeler P.G."/>
<person name="Sherpa M.D."/>
<person name="Houten S.M."/>
<person name="Horb M.E."/>
<person name="Schadt E.E."/>
</authorList>
<dbReference type="PubMed" id="28054444"/>
<dbReference type="DOI" id="10.1002/humu.23171"/>
</citation>
<scope>INVOLVEMENT IN TBS2</scope>
<scope>VARIANT TBS2 419-TRP--VAL-836 DEL</scope>
<scope>CHARACTERIZATION OF VARIANT TBS2 419-TRP--VAL-836 DEL</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] CYS-124 AND LEU-682</scope>
</reference>
<comment type="function">
<text evidence="1 4 5 7 8 11">Involved in regulation of intracellular signaling pathways during development. Specifically thought to play a role in canonical and/or non-canonical Wnt signaling pathways through interaction with DSH (Dishevelled) family proteins. The activation/inhibition of Wnt signaling may depend on the phosphorylation status. Proposed to regulate the degradation of CTNNB1/beta-catenin, thereby modulating the transcriptional activation of target genes of the Wnt signaling pathway. Its function in stabilizing CTNNB1 may involve inhibition of GSK3B activity. Promotes the membrane localization of CTNNB1. The cytoplasmic form can induce DVL2 degradation via a lysosome-dependent mechanism; the function is inhibited by PKA-induced binding to 14-3-3 proteins, such as YWHAB. Seems to be involved in morphogenesis at the primitive streak by regulating VANGL2 and DVL2; the function seems to be independent of canonical Wnt signaling and rather involves the non-canonical Wnt/planar cell polarity (PCP) pathway (By similarity). The nuclear form may prevent the formation of LEF1:CTNNB1 complex and recruit HDAC1 to LEF1 at target gene promoters to repress transcription thus antagonizing Wnt signaling. May be involved in positive regulation of fat cell differentiation. During neuronal differentiation may be involved in excitatory synapse organization, and dendrite formation and establishment of spines.</text>
</comment>
<comment type="subunit">
<text evidence="1 5 8 9 10 11 12">Can form homodimers and heterodimers with DACT2 or DACT3. Interacts with CSNK1D, PKA catalytic subunit, PKC-type kinase, CSNK2A1, CSNK2B, DVL1, DVL3, VANGL1, VANGL2, CTNND1 and HDAC1 (By similarity). Interacts with DVL2. Interacts with YWHAB; the interaction is enhanced by PKA phosphorylating DACT1 at Ser-237 and Ser-827. Interacts with CTNNB1 and HDAC1. Interacts with GSK3B; the interaction is indicative for an association of DACT1 with the beta-catenin destruction complex. Interacts with GSK3A.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3951744">
<id>Q9NYF0</id>
</interactant>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3951744">
<id>Q9NYF0</id>
</interactant>
<interactant intactId="EBI-740850">
<id>O14641</id>
<label>DVL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3951744">
<id>Q9NYF0</id>
</interactant>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3951744">
<id>Q9NYF0</id>
</interactant>
<interactant intactId="EBI-359815">
<id>P31946</id>
<label>YWHAB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell junction</location>
<location evidence="1">Synapse</location>
</subcellularLocation>
<text>Shuttles between the nucleus and the cytoplasm. Seems to be nuclear in the absence of Wnt signaling and to translocate to the cytoplasm in its presence.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NYF0-1</id>
<name>1</name>
<name>Alpha</name>
<name>Long</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NYF0-2</id>
<name>2</name>
<name>Beta</name>
<name>Short</name>
<sequence type="described" ref="VSP_044198"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="2">The C-terminal PDZ-binding motif mediates interaction with the PDZ domains of DSH (Dishevelled) family proteins.</text>
</comment>
<comment type="disease" evidence="12">
<disease id="DI-02042">
<name>Neural tube defects</name>
<acronym>NTD</acronym>
<description>Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components.</description>
<dbReference type="MIM" id="182940"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13">
<disease id="DI-04995">
<name>Townes-Brocks syndrome 2</name>
<acronym>TBS2</acronym>
<description>A form of Townes-Brocks syndrome, a rare autosomal dominant disease characterized by the triad of imperforate anus, dysplastic ears, and thumb malformations. Minor features of the condition include hearing loss, foot malformations, renal impairment with or without renal malformations, genitourinary malformations, and congenital heart disease.</description>
<dbReference type="MIM" id="617466"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the dapper family.</text>
</comment>
<comment type="sequence caution" evidence="15">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAF65569" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="15">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAD61905" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="online information" name="Dapper antagonist of beta-catenin homolog 1 (Xenopus laevis) (DACT1)">
<link uri="http://www.lovd.nl/DACT1"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EMBL" id="AL133312">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BX161433">
<property type="protein sequence ID" value="CAD61905.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF251079">
<property type="protein sequence ID" value="AAF65569.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BK000256">
<property type="protein sequence ID" value="DAA00310.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41961.1">
<molecule id="Q9NYF0-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9736.1">
<molecule id="Q9NYF0-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001072988.1">
<molecule id="Q9NYF0-2"/>
<property type="nucleotide sequence ID" value="NM_001079520.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_057735.2">
<molecule id="Q9NYF0-1"/>
<property type="nucleotide sequence ID" value="NM_016651.5"/>
</dbReference>
<dbReference type="BioGRID" id="119486">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="IntAct" id="Q9NYF0">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="MINT" id="Q9NYF0"/>
<dbReference type="STRING" id="9606.ENSP00000337439"/>
<dbReference type="iPTMnet" id="Q9NYF0"/>
<dbReference type="PhosphoSitePlus" id="Q9NYF0"/>
<dbReference type="BioMuta" id="DACT1"/>
<dbReference type="DMDM" id="34098740"/>
<dbReference type="jPOST" id="Q9NYF0"/>
<dbReference type="MassIVE" id="Q9NYF0"/>
<dbReference type="PaxDb" id="Q9NYF0"/>
<dbReference type="PeptideAtlas" id="Q9NYF0"/>
<dbReference type="PRIDE" id="Q9NYF0"/>
<dbReference type="ProteomicsDB" id="2406"/>
<dbReference type="ProteomicsDB" id="83217">
<molecule id="Q9NYF0-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="66">
<property type="antibodies" value="147 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="51339"/>
<dbReference type="Ensembl" id="ENST00000335867">
<molecule id="Q9NYF0-1"/>
<property type="protein sequence ID" value="ENSP00000337439"/>
<property type="gene ID" value="ENSG00000165617"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395153">
<molecule id="Q9NYF0-2"/>
<property type="protein sequence ID" value="ENSP00000378582"/>
<property type="gene ID" value="ENSG00000165617"/>
</dbReference>
<dbReference type="GeneID" id="51339"/>
<dbReference type="KEGG" id="hsa:51339"/>
<dbReference type="UCSC" id="uc001xdw.4">
<molecule id="Q9NYF0-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="51339"/>
<dbReference type="DisGeNET" id="51339"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000165617.14"/>
<dbReference type="GeneCards" id="DACT1"/>
<dbReference type="HGNC" id="HGNC:17748">
<property type="gene designation" value="DACT1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000165617">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="DACT1"/>
<dbReference type="MIM" id="182940">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607861">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617466">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NYF0"/>
<dbReference type="OpenTargets" id="ENSG00000165617"/>
<dbReference type="Orphanet" id="63260">
<property type="disease" value="Craniorachischisis"/>
</dbReference>
<dbReference type="Orphanet" id="268823">
<property type="disease" value="Occipital encephalocele"/>
</dbReference>
<dbReference type="Orphanet" id="857">
<property type="disease" value="Townes-Brocks syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134957283"/>
<dbReference type="eggNOG" id="ENOG502QVXB">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000183181"/>
<dbReference type="HOGENOM" id="CLU_021211_1_0_1"/>
<dbReference type="InParanoid" id="Q9NYF0"/>
<dbReference type="KO" id="K22154"/>
<dbReference type="OMA" id="FSPPKQW"/>
<dbReference type="OrthoDB" id="674318at2759"/>
<dbReference type="PhylomeDB" id="Q9NYF0"/>
<dbReference type="TreeFam" id="TF331300"/>
<dbReference type="PathwayCommons" id="Q9NYF0"/>
<dbReference type="Reactome" id="R-HSA-4641258">
<property type="pathway name" value="Degradation of DVL"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9NYF0"/>
<dbReference type="BioGRID-ORCS" id="51339">
<property type="hits" value="4 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="DACT1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="51339"/>
<dbReference type="Pharos" id="Q9NYF0">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9NYF0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 14"/>
</dbReference>
<dbReference type="RNAct" id="Q9NYF0">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000165617">
<property type="expression patterns" value="Expressed in cortical plate and 168 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9NYF0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NYF0">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0008013">
<property type="term" value="F:beta-catenin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070097">
<property type="term" value="F:delta-catenin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051018">
<property type="term" value="F:protein kinase A binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005080">
<property type="term" value="F:protein kinase C binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048619">
<property type="term" value="P:embryonic hindgut morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904864">
<property type="term" value="P:negative regulation of beta-catenin-TCF complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090090">
<property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000134">
<property type="term" value="P:negative regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046329">
<property type="term" value="P:negative regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032091">
<property type="term" value="P:negative regulation of protein binding"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030178">
<property type="term" value="P:negative regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021915">
<property type="term" value="P:neural tube development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903364">
<property type="term" value="P:positive regulation of cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032092">
<property type="term" value="P:positive regulation of protein binding"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045732">
<property type="term" value="P:positive regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030177">
<property type="term" value="P:positive regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060828">
<property type="term" value="P:regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031647">
<property type="term" value="P:regulation of protein stability"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000095">
<property type="term" value="P:regulation of Wnt signaling pathway, planar cell polarity pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR024848">
<property type="entry name" value="Dact1"/>
</dbReference>
<dbReference type="InterPro" id="IPR024843">
<property type="entry name" value="Dapper"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15919">
<property type="entry name" value="PTHR15919"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15919:SF12">
<property type="entry name" value="PTHR15919:SF12"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF15268">
<property type="entry name" value="Dapper"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="chain" description="Dapper homolog 1" id="PRO_0000191353">
<location>
<begin position="1"/>
<end position="836"/>
</location>
</feature>
<feature type="region of interest" description="Required for self-association" evidence="1">
<location>
<begin position="92"/>
<end position="156"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="3">
<location>
<begin position="92"/>
<end position="156"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal">
<location>
<begin position="132"/>
<end position="141"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal" evidence="15">
<location>
<begin position="610"/>
<end position="623"/>
</location>
</feature>
<feature type="short sequence motif" description="PDZ-binding" evidence="1">
<location>
<begin position="826"/>
<end position="836"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="9">
<location>
<position position="237"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="9">
<location>
<position position="827"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044198" evidence="15">
<location>
<begin position="213"/>
<end position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In NTD; uncertain pathological significance; does not affect interaction with DVL2; does not affect subcellular location; increases RHOA activation but decreases the ability to activate JNK; dbSNP:rs778976254." id="VAR_068427" evidence="12">
<original>R</original>
<variation>W</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation." id="VAR_036461" evidence="6">
<original>G</original>
<variation>C</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with craniorachischisis; sporadic case; unknown pathological significance." id="VAR_068428" evidence="12">
<original>D</original>
<variation>G</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In NTD; does not affect interaction with DVL2; does not affect subcellular location; results in reduced RHOA and JNK activation." id="VAR_068429" evidence="12">
<original>N</original>
<variation>K</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In TBS2; the mutant protein is stable and expressed." id="VAR_080125" evidence="13">
<location>
<begin position="419"/>
<end position="836"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34015825." id="VAR_053057">
<original>D</original>
<variation>N</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17832998." id="VAR_053058" evidence="14">
<original>A</original>
<variation>V</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17094821." id="VAR_053059">
<original>S</original>
<variation>A</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation; dbSNP:rs1198900887." id="VAR_036462" evidence="6">
<original>S</original>
<variation>L</variation>
<location>
<position position="682"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs698025." id="VAR_053060">
<original>G</original>
<variation>S</variation>
<location>
<position position="697"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with closed spina bifida; sporadic case; unknown pathological significance; dbSNP:rs1028180302." id="VAR_068430" evidence="12">
<original>V</original>
<variation>G</variation>
<location>
<position position="702"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs773720154." id="VAR_068431" evidence="12">
<original>D</original>
<variation>G</variation>
<location>
<position position="800"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with encephalocele; sporadic case; unknown pathological significance." id="VAR_068432" evidence="12">
<original>T</original>
<variation>K</variation>
<location>
<position position="808"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear export; when associated with A-136." evidence="8">
<original>L</original>
<variation>A</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear export; when associated with A-132." evidence="8">
<original>I</original>
<variation>A</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with YWHAB. Abolishes interaction with YWHAB; when associated with A-827.">
<original>S</original>
<variation>A</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial nuclear accumulation upon LMB treatment." evidence="8">
<original>KK</original>
<variation>AA</variation>
<location>
<begin position="622"/>
<end position="623"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with YWHAB; when associated with A-237.">
<original>S</original>
<variation>A</variation>
<location>
<position position="827"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8R4A3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15580286"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16446366"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17197390"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18936100"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21262972"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21718540"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22470507"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22610794"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28054444"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<sequence length="836" mass="90174" checksum="10B77DC5B7C73485" modified="2003-08-15" version="2">MKPSPAGTAKELEPPAPARGEQRTAEPEGRWREKGEADTERQRTRERQEATLAGLAELEYLRQRQELLVRGALRGAGGAGAAAPRAGELLGEAAQRSRLEEKFLEENILLLRKQLNCLRRRDAGLLNQLQELDKQISDLRLDVEKTSEEHLETDSRPSSGFYELSDGASGSLSNSSNSVFSECLSSCHSSTCFCSPLEATLSLSDGCPKSADLIGLLEYKEGHCEDQASGAVCRSLSTPQFNSLDVIADVNPKYQCDLVSKNGNDVYRYPSPLHAVAVQSPMFLLCLTGNPLREEDRLGNHASDICGGSELDAVKTDSSLPSPSSLWSASHPSSSKKMDGYILSLVQKKTHPVRTNKPRTSVNADPTKGLLRNGSVCVRAPGGVSQGNSVNLKNSKQACLPSGGIPSLNNGTFSPPKQWSKESKAEQAESKRVPLPEGCPSGAASDLQSKHLPKTAKPASQEHARCSAIGTGESPKESAQLSGASPKESPSRGPAPPQENKVVQPLKKMSQKNSLQGVPPATPPLLSTAFPVEERPALDFKSEGSSQSLEEAHLVKAQFIPGQQPSVRLHRGHRNMGVVKNSSLKHRGPALQGLENGLPTVREKTRAGSKKCRFPDDLDTNKKLKKASSKGRKSGGGPEAGVPGRPAGGGHRAGSRAHGHGREAVVAKPKHKRTDYRRWKSSAEISYEEALRRARRGRRENVGLYPAPVPLPYASPYAYVASDSEYSAECESLFHSTVVDTSEDEQSNYTTNCFGDSESSVSEGEFVGESTTTSDSEESGGLIWSQFVQTLPIQTVTAPDLHNHPAKTFVKIKASHNLKKKILRFRSGSLKLMTTV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

